Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

In Salt Lake City, 30-year-old Julie (a pseudonym) also felt like Ozempic was the answer to her prayers. She had a history of ...

Earlier this year, Trump sparked suspicions he could be using weight-loss drugs as his physical examination revealed quite a ...

Weight management drugs like the GLP-1 can significantly improve health outcomes, but their exorbitant prices often limit ...

New research unveils a groundbreaking quintuple agonist that targets multiple pathways for effective treatment of obesity and ...

Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future ...

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

This potential acquisition arrives at a pivotal moment for Pfizer. The company has been navigating a post-pandemic downturn with declining revenues following the wind-down of its COVID-related ...

"The findings are very exciting,” said Dr. Prachi Singh at Pennington Biomedical. “This supports the growing understanding ...

Despite its dramatic ability to cut pounds by curbing appetite, high costs, unpleasant side effects, and health complications drive many users away. Younger adults and men are especially likely to ...